Back to User profile » Professor Francesco Blasi
Papers published by Professor Francesco Blasi:
Tackling Neutrophilic Inflammation in Bronchiectasis: From Macrolides to Cathepsin C Inhibitors
Gramegna A, Premuda C, Putti G, Piedepalumbo FV, Misuraca S, Ori M, Nigro M, Simonetta E, Aliberti S, Blasi F
Journal of Inflammation Research 2026, 19:558745
Published Date: 11 April 2026
Severe Asthma and Sleep Disorders: A Severe Asthma Network Italy (SANI) Registry Analysis
Ferri S, Marzio V, Cavaglià E, Valli N, Bagnardi V, Oriecuia C, Sala I, Cardini C, Sirena C, Paoletti G, Blasi F, Paggiaro P, Canonica GW, Heffler E
Journal of Asthma and Allergy 2025, 18:1661-1673
Published Date: 1 December 2025
Real-World Use and Treatment Outcomes of Ceftaroline Fosamil in Patients with Complicated Skin and Soft Tissue Infection: A Multinational Retrospective Study
Ferry T, Gogos C, Soriano A, Blasi F, Ansari W, Kantecki M, Schweikert B, Luna G, Bassetti M
Infection and Drug Resistance 2024, 17:2773-2783
Published Date: 4 July 2024
Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?
Cazzola M, Rogliani P, Blasi F
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1959-1964
Published Date: 8 September 2023
One-Year Evolution of Symptoms and Health Status of the COPD Multi-Dimensional Phenotypes: Results from the Follow-Up of the STORICO Observational Study
Incalzi RA, Blasi F, Scichilone N, Zullo A, Simoni L, Canonica GW
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1007-1020
Published Date: 20 April 2021
Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
Puggioni F, Brussino L, Canonica GW, Blasi F, Paggiaro P, Caminati M, Latorre M, Heffler E, Senna G
Journal of Asthma and Allergy 2020, 13:599-604
Published Date: 10 November 2020
Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
Mantero M, Radovanovic D, Santus P, Blasi F
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2319-2333
Published Date: 30 July 2018
Pneumococcal vaccination and chronic respiratory diseases
Froes F, Roche N, Blasi F
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3457-3468
Published Date: 5 December 2017
Acute exacerbations of COPD: risk factors for failure and relapse
Mantero M, Rogliani P, Di Pasquale M, Polverino E, Crisafulli E, Guerrero M, Gramegna A, Cazzola M, Blasi F
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2687-2693
Published Date: 8 September 2017
Perception of symptoms and quality of life – comparison of patients’ and physicians’ views in the COPD MIRROR study
Celli B, Blasi F, Gaga M, Singh D, Vogelmeier C, Pegoraro V, Caputo N, Agusti A
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2189-2196
Published Date: 27 July 2017
Switching treatments in COPD: implications for costs and treatment adherence
Braido F, Lavorini F, Blasi F, Baiardini I, Canonica GW
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2601-2608
Published Date: 3 December 2015
Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial
Santus P, Radovanovic D, Di Marco S, Valenti V, Raccanelli R, Blasi F, Centanni S, Bussotti M
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1917-1923
Published Date: 11 September 2015
Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication
Blasi F, Tarsia P, Mantero M, Morlacchi LC, Piffer F
Therapeutics and Clinical Risk Management 2013, 9:55-64
Published Date: 12 February 2013